A citation-based method for searching scientific literature

Su Hyun Chae, Chulmin Lee, Sang Hee Yoon, Seung Hyuk Shim, Sun Joo Lee, Soo Nyung Kim, Sochung Chung, Ji Young Lee. J Korean Med Sci 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Sarcopenia and prognosis of advanced cancer patients receiving immune checkpoint inhibitors: A comprehensive systematic review and meta-analysis.
Han-Yu Deng, Zi-Jia Chen, Xiao-Ming Qiu, Da-Xing Zhu, Xiao-Jun Tang, Qinghua Zhou. Nutrition 2021
1
100


Is increased neutrophil lymphocyte ratio remarking the inflammation in sarcopenia?
Zeynel Abidin Öztürk, Seval Kul, İbrahim Halil Türkbeyler, Zeynel Abidin Sayıner, Azer Abiyev. Exp Gerontol 2018
17
100


Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS).
Alfonso J Cruz-Jentoft, Francesco Landi, Stéphane M Schneider, Clemente Zúñiga, Hidenori Arai, Yves Boirie, Liang-Kung Chen, Roger A Fielding, Finbarr C Martin, Jean-Pierre Michel,[...]. Age Ageing 2014
856
100

Cancer-related inflammation.
Alberto Mantovani, Paola Allavena, Antonio Sica, Frances Balkwill. Nature 2008
100

The association between systemic inflammatory markers and sarcopenia: Results from the West China Health and Aging Trend Study (WCHAT).
Wan-Yu Zhao, Yan Zhang, Li-Sha Hou, Xin Xia, Mei-Ling Ge, Xiao-Lei Liu, Ji-Rong Yue, Bi-Rong Dong. Arch Gerontol Geriatr 2021
9
100

Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases.
Angelika M Starzer, Ariane Steindl, Maximilian J Mair, Carola Deischinger, Anika Simonovska, Georg Widhalm, Brigitte Gatterbauer, Karin Dieckmann, Gerwin Heller, Matthias Preusser,[...]. Br J Cancer 2021
2
100


Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial.
Adrian S Dobs, Ralph V Boccia, Christopher C Croot, Nashat Y Gabrail, James T Dalton, Michael L Hancock, Mary A Johnston, Mitchell S Steiner. Lancet Oncol 2013
198
100

Inflammation and sarcopenia: A systematic review and meta-analysis.
Giulia Bano, Caterina Trevisan, Sara Carraro, Marco Solmi, Claudio Luchini, Brendon Stubbs, Enzo Manzato, Giuseppe Sergi, Nicola Veronese. Maturitas 2017
201
100

Definition and classification of cancer cachexia: an international consensus.
Kenneth Fearon, Florian Strasser, Stefan D Anker, Ingvar Bosaeus, Eduardo Bruera, Robin L Fainsinger, Aminah Jatoi, Charles Loprinzi, Neil MacDonald, Giovanni Mantovani,[...]. Lancet Oncol 2011
100

Sarcopenia.
Alfonso J Cruz-Jentoft, Avan A Sayer. Lancet 2019
441
100


Serum markers of inflammation and oxidative stress in sarcopenia.
Busra Can, Ozgur Kara, Muhammet Cemal Kizilarslanoglu, Gunes Arik, Gozde Sengul Aycicek, Fatih Sumer, Ramazan Civelek, Canan Demirtas, Zekeriya Ulger. Aging Clin Exp Res 2017
56
100

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
100

Skeletal muscle cells actively shape (auto)immune responses.
Ali Maisam Afzali, Thomas Müntefering, Heinz Wiendl, Sven G Meuth, Tobias Ruck. Autoimmun Rev 2018
23
100

Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy.
Yoshio Nakamura, Shigehisa Kitano, Akira Takahashi, Arata Tsutsumida, Kenjiro Namikawa, Keiji Tanese, Takayuki Abe, Takeru Funakoshi, Noboru Yamamoto, Masayuki Amagai,[...]. Oncotarget 2016
103
100


Skeletal muscle mass predicts the outcome of nivolumab treatment for non-small cell lung cancer.
Mariko Tsukagoshi, Takehiko Yokobori, Toshiki Yajima, Toshitaka Maeno, Kimihiro Shimizu, Akira Mogi, Kenichiro Araki, Norifumi Harimoto, Ken Shirabe, Kyoichi Kaira. Medicine (Baltimore) 2020
12
100

Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer.
Eun Young Kim, Young Saing Kim, Inkeun Park, Hee Kyung Ahn, Eun Kyung Cho, Yu Mi Jeong. J Thorac Oncol 2015
110
100

Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer.
Shirish Gadgeel, Delvys Rodríguez-Abreu, Giovanna Speranza, Emilio Esteban, Enriqueta Felip, Manuel Dómine, Rina Hui, Maximilian J Hochmair, Philip Clingan, Steven F Powell,[...]. J Clin Oncol 2020
194
100

Prognostic Significance of Sarcopenia With Inflammation in Patients With Head and Neck Cancer Who Underwent Definitive Chemoradiotherapy.
Yeona Cho, Jun Won Kim, Ki Chang Keum, Chang Geol Lee, Hei Cheul Jeung, Ik Jae Lee. Front Oncol 2018
41
100

Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer.
M P Petrova, I S Donev, M A Radanova, M I Eneva, E G Dimitrova, G N Valchev, V T Minchev, M S Taushanova, M V Boneva, T S Karanikolova,[...]. Clin Exp Immunol 2020
5
100

The Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung Cancer.
Eun Young Kim, Young Saing Kim, Ja-Young Seo, Inkeun Park, Hee Kyung Ahn, Yu Mi Jeong, Jeong Ho Kim, Nambeom Kim. PLoS One 2016
37
100

Sarcopenia as a prognostic factor among patients with stage III melanoma.
Michael S Sabel, Jay Lee, Shijie Cai, Michael J Englesbe, Stephen Holcombe, Stewart Wang. Ann Surg Oncol 2011
196
100

Inflammation and cancer: advances and new agents.
Shanthini M Crusz, Frances R Balkwill. Nat Rev Clin Oncol 2015
514
100

Peripheral Blood Biomarkers Associated with Clinical Outcome in Non-Small Cell Lung Cancer Patients Treated with Nivolumab.
Junko Tanizaki, Koji Haratani, Hidetoshi Hayashi, Yasutaka Chiba, Yasushi Nakamura, Kimio Yonesaka, Keita Kudo, Hiroyasu Kaneda, Yoshikazu Hasegawa, Kaoru Tanaka,[...]. J Thorac Oncol 2018
97
100

Understanding how we age: insights into inflammaging.
Daniel Baylis, David B Bartlett, Harnish P Patel, Helen C Roberts. Longev Healthspan 2013
200
100

Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis.
Vickie E Baracos, Tony Reiman, Marina Mourtzakis, Ioannis Gioulbasanis, Sami Antoun. Am J Clin Nutr 2010
271
100

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer.
Stephen J Bagley, Shawn Kothari, Charu Aggarwal, Joshua M Bauml, Evan W Alley, Tracey L Evans, John A Kosteva, Christine A Ciunci, Peter E Gabriel, Jeffrey C Thompson,[...]. Lung Cancer 2017
265
100

Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab.
Benjamin Weide, Alexander Martens, Jessica C Hassel, Carola Berking, Michael A Postow, Kees Bisschop, Ester Simeone, Johanna Mangana, Bastian Schilling, Anna Maria Di Giacomo,[...]. Clin Cancer Res 2016
335
100

Molecular and cellular insights into T cell exhaustion.
E John Wherry, Makoto Kurachi. Nat Rev Immunol 2015
100

Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review.
Shlomit Strulov Shachar, Grant R Williams, Hyman B Muss, Tomohiro F Nishijima. Eur J Cancer 2016
388
100

Sarcopenia predicts prognosis of patients with renal cell carcinoma: A systematic review and meta-analysis.
Xu Hu, Du-Wu Liao, Zhi-Qiang Yang, Wei-Xiao Yang, San-Chao Xiong, Xiang Li. Int Braz J Urol 2020
5
100

Clinical impact of skeletal muscle area in patients with non-small cell lung cancer treated with anti-PD-1 inhibitors.
Kazuki Takada, Yasuto Yoneshima, Kentaro Tanaka, Isamu Okamoto, Mototsugu Shimokawa, Sho Wakasu, Shinkichi Takamori, Gouji Toyokawa, Taro Oba, Atsushi Osoegawa,[...]. J Cancer Res Clin Oncol 2020
15
100

Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A "hypothesis-generator" preliminary report.
Alessio Cortellini, Lucilla Verna, Giampiero Porzio, Federico Bozzetti, Pierpaolo Palumbo, Carlo Masciocchi, Katia Cannita, Alessandro Parisi, Davide Brocco, Nicola Tinari,[...]. Thorac Cancer 2019
33
100

Impact of body composition, nutritional and inflammatory status on outcome of non-small cell lung cancer patients treated with immunotherapy.
Cinzia Baldessari, Giorgia Guaitoli, Filippo Valoriani, Riccardo Bonacini, Raffaella Marcheselli, Linda Reverberi, Annarita Pecchi, Renata Menozzi, Pietro Torricelli, Federica Bertolini,[...]. Clin Nutr ESPEN 2021
2
100

Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis.
Yongmei Yin, Jun Wang, Xuedong Wang, Lan Gu, Hao Pei, Shougang Kuai, Yingying Zhang, Zhongbo Shang. Clinics (Sao Paulo) 2015
88
100


Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy.
Tuba N Gide, Camelia Quek, Alexander M Menzies, Annie T Tasker, Ping Shang, Jeff Holst, Jason Madore, Su Yin Lim, Rebecca Velickovic, Matthew Wongchenko,[...]. Cancer Cell 2019
175
100

Total and appendicular lean mass reference ranges for Australian men and women: the Geelong osteoporosis study.
Haslinda Gould, Sharon L Brennan, Mark A Kotowicz, Geoffrey C Nicholson, Julie A Pasco. Calcif Tissue Int 2014
66
100

Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia.
Marc E Martignoni, Phillipp Kunze, Wulf Hildebrandt, Beat Künzli, Pascal Berberat, Thomas Giese, Oliver Klöters, Jürgen Hammer, Markus W Büchler, Nathalia A Giese,[...]. Clin Cancer Res 2005
108
100

Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10.
Yu-Dong Rong, Ai-Lin Bian, Hui-Ying Hu, Yue Ma, Xin-Zi Zhou. BMC Geriatr 2018
52
100

Interleukin-1 beta and interleukin-6 release by peripheral blood monocytes in head and neck cancer.
O Gallo, A M Gori, M Attanasio, F Martini, B Giusti, M Boddi, E Gallina, O Fini, R Abbate. Br J Cancer 1993
24
100

Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials.
Jennifer S Temel, Amy P Abernethy, David C Currow, John Friend, Elizabeth M Duus, Ying Yan, Kenneth C Fearon. Lancet Oncol 2016
274
100

Body composition by DXA.
John A Shepherd, Bennett K Ng, Markus J Sommer, Steven B Heymsfield. Bone 2017
96
100

A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-α.
Ai-Lin Bian, Hui-Ying Hu, Yu-Dong Rong, Jian Wang, Jun-Xiong Wang, Xin-Zi Zhou. Eur J Med Res 2017
77
100

T cell exclusion, immune privilege, and the tumor microenvironment.
Johanna A Joyce, Douglas T Fearon. Science 2015
945
100

Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy.
Mehmet Asim Bilen, Dylan J Martini, Yuan Liu, Julie M Shabto, Jacqueline T Brown, Milton Williams, Amir I Khan, Alexandra Speak, Colleen Lewis, Hannah Collins,[...]. Oncologist 2020
18
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.